The global weight-loss drug market is experiencing exceptional growth, projected to expand from around $144.6 billion in 2023 ...

Novo Nordisk is rapidly ceding market share to Eli Lilly. And the paradigm shift is showing up in Novo Nordisk stock.

The size of India’s insulin market was an estimated Rs 4,404 crore in April this year, with Indian players making steady ...

Novo Nordisk and Eli Lilly , the leaders in the highly lucrative ... a senior executive told Reuters. France's Sanofi to invest at least $20 billion in US through 2030 Sanofi plans to invest ...

Jefferies has predicted more small tuck-in deals to come, as biotechs struggle to access capital despite key clinical ...

Regeneron’s shares have declined nearly 17% following the failure of the company’s Dupixent follow-up itepekimab.

The large molecule injectable drugs market is anticipated to expand at a CAGR of ~9% during the forecast period. Key drivers ...

June 3, 2025 expert reaction to observational study on low calorie diets and depressive symptoms . An observational study published in BMJ Nutrition, Prevention & Health looks at ...

The global drug device combination products market, valued at US$224.70 billion in 2024, stood at US$243.02 billion in 2025 ...

Taking a statin medication is an effective, safe, and low-cost way to lower cholesterol and reduce risk of cardiovascular ...

The lawsuit takes aim at Eli Lilly, Novo Nordisk, and Sanofi, companies that dominate the global diabetes drug market and the three major pharmacy benefit managers CVS Caremark, Express Scripts ...

The attorney general described the agreements as "huge wins" for New Mexico, which is home to more than 200,000 adults with ...